Cytokinetics Inc. buy Barclays PLC
Start price
23.05.24
/
50%
€46.40
Target price
23.05.25
€87.72
Performance (%)
-42.24%
End price
24.05.25
€26.80
Summary
This prediction ended on 24.05.25 with a price of €26.80. Massive losses of -42.24% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | -0.778% | -0.778% | 118.289% |
| iShares Core DAX® | 2.573% | 3.502% | 8.408% |
| iShares Nasdaq 100 | 4.858% | 0.654% | 28.383% |
| iShares Nikkei 225® | 5.590% | -0.246% | 52.915% |
| iShares S&P 500 | 3.250% | 2.083% | 24.370% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Barclays PLC from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.60
03.09.25
03.09.25
€61.04
03.09.26
03.09.26
59.52%
07.08.26
07.08.26
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€55.52
06.04.26
06.04.26
€82.47
06.04.27
06.04.27
21.58%
07.08.26
07.08.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€53.50
28.01.26
28.01.26
€72.55
28.01.27
28.01.27
24.04%
07.08.26
07.08.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
08.05.25
08.05.25
€46.79
08.05.26
08.05.26
127.86%
09.05.26
09.05.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.60
24.04.25
24.04.25
€48.44
24.04.26
24.04.26
63.39%
25.04.26
25.04.26